chrisvoncsefalvay/vaers-outcomes huggingface dataset:
lost appetite for 3 days; chills; This spontaneous case was reported by a patient and describes the occurrence of DECREASED APPETITE (lost appetite for 3 days) and CHILLS (chills) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002C21A and 002C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-May-2021, the patient experienced DECREASED APPETITE (lost appetite for 3 days) and CHILLS (chills). At the time of the report, DECREASED APPETITE (lost appetite for 3 days) and CHILLS (chills) outcome was unknown.            Action taken with mRNA-1273 in response to the events was not applicable. No concomitant medication details was reported. No treatment medication details was reported.    This case was linked to MOD-2021-095595 (Patient Link).
On Wednesday, November 25 I went to a routine check up for the baby.  The doctor could no longer find the heartbeat. She stated that it stopped growing on Monday because of measurements.    12/07/09: Vaccine record (no lot #) and Hospital admission records received for dates of service 11/20/09 to 11/28/09.  Dx:  Missed abortion at 14 weeks.  Gravida 3 Para 2 presented with missed abortion.  Dilation, evacuation, suction and curettage performed.
08/29/21 The patient presents with 74 year old male with a medical HX of HTN, Sleep apnea, anemia, TIA, Prostate caner presents with a severe left sided headache onset of x1 week. Patient reports of associated blurred vision prior to arriving to the ED but no longer blurred and can see fine with no loss of vision. Patient denies any LOC, shortness of breath, chest pain, abdominal pain, traumatic injuries or vomiting. .  The onset was 1  weeks ago.  The course/duration of symptoms is constant.  Location: Left temporal generalized. Radiating pain: none. The character of symptoms is sharp.  The degree at onset was severe.  The degree at maximum was severe.  The degree at present is severe.  History mainly
I was in for a pulmonary function test; they administered albuterol that sent me into atrial fibrillation. I was feeling panic, had chest pains, having a hard time breathing. I went immediately to the emergency room. They ran an CT scan, EKG, did a chest, bloodwork, that revealed that I was in A-fib. I was given medication to bring my heart back into rhythm. I was observed for a couple of hours, then released with the advice to follow up with my PCP and cardiologist. I am currently under my doctor's care as I am still having A-fib attacks.
Received vaccines on 10/2/08.  Woke up on 10/3/08 - right upper arm red, sore, swollen, warm to touch, chills.  On 10/4/08 patient stated unable to lift arm.  Today redness, swelling, warmth is decreased he states.
Adverse Event: Unusual/increased pre-menstrual symptoms: irritability/variable moods, breast soreness, cramping, fatigue - day of vaccine and day after vaccine (3/13-3/14/2021) Treatment: Increase water intake, gentle yoga, rest Outcome: No improvement Unusual/increased menstrual symptoms:  heavier than normal flow, increased irritability/variable moods, increased fatigue - (upon onset and throughout menses 3/15-3/17/2021) Treatment: Increase water intake, gentle yoga, added dietary/herbal remedy night of 3/16 & morning of 3/17 (tea of raw cacao, red clover, raspberry leaf, yarrow, linden, motherwort, angelica root, local honey) Outcome: irritability and cramping decreased after cacao & herbs were added; menstrual flow is still heavier than normal and fatigue is still quite pronounced
This case was reported by a consumer via call center representative and described the occurrence of extensive swelling of vaccinated limb in a 69-year-old female patient who received SHINGRIX for prophylaxis. On 19th October 2018, the patient received the 1st dose of SHINGRIX (subcutaneous) 50 ug. On 19th October 2018, unknown after receiving SHINGRIX, the patient experienced intramuscular formulation administered by other route. On 20th October 2018, the patient experienced extensive swelling of vaccinated limb, generalized aching, dizziness, erythema of extremities, mass, influenza like illness, nausea and feeling bad. On an unknown date, the outcome of the extensive swelling of vaccinated limb, generalized aching, dizziness, erythema of extremities, mass, influenza like illness, nausea and feeling bad were recovering/resolving and the outcome of the intramuscular formulation administered by other route was unknown. It was unknown if the reporter considered the extensive swelling of vaccinated limb, generalized aching, dizziness, erythema of extremities, mass, influenza like illness, nausea and feeling bad to be related to SHINGRIX. Additional details were provided as follows: The patient received a dose of SHINGRIX subcutaneously, which led to incorrect route of vaccination. The patient woke up the next morning after vaccination and felt like she had been hit by a truck. Her whole body hurt from her head to her toes. She felt like she had the flu. Her arm was red and swollen from her shoulder to her elbow. She went back to sleep and felt even worse when she woke up. She felt dizzy and though she was going to throw up. The patient was starting to feel better, on the date of reporting. The patient had denied permission to contact their physician.
1 of 2 pts over the last month, who exp h/a, arthralgias, fever & inject site react following immun for puncture wound; both pts were immunized from the same vial;
Pt developed autoimmune hemolytic anemia. (This is seen in increased frequency in patients with CLL.  Unknown if related to vaccine.).  Pt had "tennis ball" sized L axillary node and fever of 103 in the 1-2 days after the booster dose.  On exam 11/4/21 L axillary node was 1 cm in size.
t104.3 ax temp, hot swollen, hard @ inject site; given APAP;
Onset on 5/9/10 of itching and red patch on (R) anterior thigh. Treated as insect bite w/ cellulitis. Uncertain if that or vaccine related.
A spike in blood sugars which is normally controlled (+374), injection site lump that is half-dollar size and painful, nausea, low-grade fever, over all tiredness.
This spontaneous report as received from a physician, via field representative, refers to a 5 patients of unknown age and gender. In 2013 (reported as in the past few weeks) the patients were vaccinated with GARDASIL (dose, route and site of administration not reported). On an unknown dates (reported as recommended observation period after GARDASIL administration) the patients fainted. The outcome of fainting was not reported. The relatedness between GARDASIL administration and fainting was not reported. Same reporter link: 1307USA014696. Additional information has been requested.
I was getting my second Moderna vaccine booster. After swabbing my right shoulder, the nurse pinched the skin and inserted the needle of the prefilled syringe into my skin. As the nurse depressed the plunger, I heard a popping sound and saw that the needle hub had separated from the syringe body, with the syringe contents sprayed all over my skin. It was unclear how much of the vaccine had been injected before the defect occurred. Under the protocol, I was given another full dose.  If there was a particulate contaminant that clogged the needle and caused the syringe to overpressurize, there is a chance that it has now been implanted into my right shoulder. I will be monitoring it.
Facial muscle weakness developed in left jaw within 4-5 weeks. Within two weeks  of that complete paralysis of left eye, blocking vision and making employment nearly impossible. Went to Dr. where blood work indicated his immune system was working overtime. When eye started drooping, within one week went to ER. No major cause. Best educated diagnosis ... Bell's Palsy, perhaps instigated by the exposure to virus in vaccine.
Patient developed an indurated, erythematous, painful rash involving mast of the upper outer arm. In central, vesicular rash at the injection site left arm.
warmth at injection site; soreness; very serious fatigue; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (warmth at injection site), MYALGIA (soreness) and FATIGUE (very serious fatigue) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, the patient experienced VACCINATION SITE WARMTH (warmth at injection site), MYALGIA (soreness) and FATIGUE (very serious fatigue). At the time of the report, VACCINATION SITE WARMTH (warmth at injection site), MYALGIA (soreness) and FATIGUE (very serious fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2021, Heart rate: increased (abnormal) Rapid heart rate for 10 minutes and stopped.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient has normal BMI.  No concomitant medications were provided by the reporter. No treatment information was provided by the reporter.   This case was linked to MOD-2021-333346, MOD-2021-333347 (Patient Link).
1 day after immunizations pt. c/o increased temp 103 and swelling @ face-no trouble breathing.
This case was reported by a consumer via call center representative and described the occurrence of headache in a female patient who received SHINGRIX for prophylaxis. On 28th January 2019, the patient received the 1st dose of SHINGRIX. On 29th January 2019, 1 days after receiving SHINGRIX, the patient experienced headache, pain, tiredness and chills. On an unknown date, the outcome of the headache, pain, tiredness and chills were unknown. It was unknown if the reporter considered the headache, pain, tiredness and chills to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient experienced headache, achiness, tiredness and chills. The reporter did not give consent to follow up. No further details were provided.
Vaccine was given 1/30/09-same day Patient developed repetitive Head nodding 3-4 episodes per hour per parents. Observed 1 episode in clinic
I did not contact my family doctor.  I have had A Fib for over 10 years.  1 day after first vaccine, i began a fib but was very different than other episodes I have had.  My pulse went into a fib but went up and down from high to low with stopping.  It didn't go over 110 but not below 82.  It just ran up and down.  This started on August 26, 2021(day after shot) and didn't stop until Sept. 17, 2021 at 9:00 pm.  I have never had something like this with A Fib.  My BP remained low and  I do not panic but rest and handle the A Fib.  I did not take the second shot as I was afraid it might trigger another episode.  I am fine now,  a little tired is all. The person who gave me the first dose asked me to contact this site and report this.
2/6/21 arms became swollen, bright red, tender, about 3 cm below injection site. Rash approx 7cmx5cm. By 2/8/21 rash has started lightening, is no longer tender or swollen, and has started itching.
MOTHER NOTIFYED NURSE AT IHS CLINIC OF THURSDAY 02/07/2007 THAT CHILD HAD A HARD,RED HOT SILVER DOLLAR SIZE LUMP WITH RED STICKS EXTENDING DOWN TO ELBOW AT INJECTION SITE, ALSO C/O HA. UNABLE TO GET TO IHS CLINIC IN LAMME DEER,MT. SO TAKEN TO CLINIC IN COLSTRIP MT. MOTHER INFORMED NURSE AT LAME DEER CLINIC THAT CHILD HAD AN INFECTION AND WAS PUT ON CLYDAMYCIN.
Pt began with N/V and progressed into fever, gen weakness, blurred vision by that same night.  Sx continued through the next day and fever broke <24hrs after onset. By 5/18, pt reports he felt much better but still had some weakness.  Blurred vision resolved.  Pt visited clinic 5/19 to report reaction and visited PCP later that day.
no adverse event; Expired product administered; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired product administered) and NO ADVERSE EVENT (no adverse event) in a 3-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch nos. 065H22A and 065H22A) for COVID-19 prophylaxis.    Co-suspect products included non-company products DIPHTHERIA VACCINE TOXOID, PERTUSSIS VACCINE ACELLULAR, TETANUS VACCINE TOXOID (DTAP) for an unknown indication and POLIO VACCINE (POLIO) for an unknown indication.    The patient had no relevant medical history/conditions, allergy, concomitant diseases and risk factor. The patient had received other vaccines in the 4 weeks prior to COVID-19 vaccine.    On 07-Jun-2023, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .25 milliliter. On 11-Jul-2023, received second dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) dosage was changed to .25 milliliter. On 11-Jul-2023, the patient received dose of DIPHTHERIA VACCINE TOXOID, PERTUSSIS VACCINE ACELLULAR, TETANUS VACCINE TOXOID (DTAP) (unknown route) 1 dosage form and dose of POLIO VACCINE (POLIO) (unknown route) 1 dosage form. On 11-Jul-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired product administered). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired product administered) and NO ADVERSE EVENT (no adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired product administered).    No concomitant medication was reported. It was reported that a pediatrician inadvertently administered an expired dose of the bivalent vaccine (blue cap) to a 3 year old patient. The expiry date for dose 2 was reported as 13-Jun-2023. No adverse events were reported after the administration. No treatment medication was reported.   Reporter did not allow further contact
12:25 "sudden pressure to face" x 15-20 seconds.  Took pt to triage via wheel chair.   EMT & MD at side.   Vitals 140/63, 114, 20  02 98% RA  Pt husb states hx extreme anxiety Pt DC home stable
pt recv vax 5AUG96 & returned 13NOV96 had dime size palpable knot;no redness @ inj site of Td;returned 20MAR97;had dime size scar c/o tenderness to see MD returned 10JUL97;reports had cyst removed from prior Td site APR97;
My arm became red, swollen, sore, and itchy at the injection site on Day 8 after taking shot one of Moderna covid vaccination.
Exposed to covid over the weekend then allergy sx (symptoms) started 24May2022 then + 27May2022 Ag test; Exposed to covid over the weekend then allergy sx (symptoms) started 24May2022 then + 27May2022 Ag test; This is a spontaneous report received from a non-contactable reporter(s) (Nurse).  A 36-year-old male patient received BNT162b2 (BNT162B2), on 27Jan2021 as dose 1, single (Lot number: EL3247), on 17Feb2021 as dose 2, single (Lot number: EL3247) and on 07Dec2021 as dose 3 (booster), single (Lot number: FF2589) at the age of 36 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 24May2022, outcome "unknown" and all described as "Exposed to covid over the weekend then allergy sx (symptoms) started 24May2022 then + 27May2022 Ag test". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (27May2022) Positive, notes: Nasal Swab. It was unknown if therapeutic measures were taken as a result of covid-19. Clinical course: Facility type vaccine was Workplace clinic. It was unknown: If other vaccine in four weeks and If COVID prior vaccination. COVID tested post vaccination: Yes.  No follow-up attempts are possible. No further information is expected.
Developed Rheumatoid arthritis 2 months after 2 shot.  Started with scalp lesions in May, then right knee pain and hand pain in July.   Used topical medication in beginning with no relief.
She got her vaccine, she didn't have any reaction until the next day when her family could not reach her and they sent somebody to help her, they could hear her but could not get up, and they found her on the floor, like a dishrag, no strength, could not move, could not stand, could not dial the phone, could not answer the door.  She could yell but they could not hear her.  The fire Department broke the door down and rescued her.   They took her to Community Hospital.  She was put in ICU, saw a cardiologist who said that she had a heart attack, and her personal cardiologist said he did not feel it was a heart attack as she had just been tested and it was fine.  She was then sent to rehab and was there for over a month.  She went around 9/30/22 to 10/1/22, and she got home last Monday, 11/28/22.  She is far from well, she has a cane, walker, hospital bed and is still suffering.  She did use a cane for sporadic flare up for arthritis of her knee.  She wants to walk upright and be as she was prior to the vaccine.  She did regain her strength and is able to walk which she did not feel she would walk again.  She is on multiple medicines now and has appointments with doctors.  She is going to her cardiologist tomorrow.   She now has to have an aide to assist her as she is not able to clean herself and not able to take care of herself.  She is also having home therapy come and assist her with mobility.  The rehab unit she was in was Rehab Center.
Started feeling a lump forming under my right armpit. At first it wasn't hurting that much I just felt it was normal of the swelling and soreness, but then I started feeling more pain at night time when I tried to sleep. On Monday the 25th woke up feeling more pain bigger then a pea on my right armpit had a fever of 100.1 in the morning. I went to the doc around the same day in the afternoon. The doc said it was an infection and inflamed from the vaccine I recently got on Friday.
sz, rash, fever occurred 11 days post vax; poss encephalitis; excessive imbalance, loose stools, watery eyes, dec appetite, limp, crabby; papular rash, stiffened up, arched back, sl tired, screamed, shaking, eyes rolled into head;
Patient came into the office for 2nd dose for the covid vaccine. It was scheduled for Moderna, but patient had Pfizer for the first dose. Patient was given moderna for the 2nd dose.
rash (with redness) at site of injection.; rash (with redness) at site of injection/rash was spreading down and it went from the right deltoid to the area around the elbow; This case was reported by a pharmacist via call center representative and described the occurrence of injection site erythema in a 73-year-old female patient who received Herpes zoster (Shingrix) (batch number 3XR3X, expiry date 19th September 2022) and (batch number 5C55P, expiry date 19th September 2022) for prophylaxis.   On 19th August 2020, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, the dose was an unknown dose. On 20th August 2020, 1 day after receiving Shingrix, the patient experienced injection site erythema and red rash. On 26th August 2020, the outcome of the injection site erythema and red rash were recovered/resolved.   It was unknown if the reporter considered the injection site erythema and red rash to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix in right deltoid. After receiving Shingrix, the patient started to develop a rash with redness at the site of injection.  The patient noticed that, the rash was spreading down and it went from the right deltoid to the area around the elbow. Pharmacist confirmed the status of the patient on 26th August 2020 and wondered about the safety of a 2nd dose given the reaction of the 1st dose. The reporter did not consent to follow up. This case was linked with case US2020172527, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020172527:Same reporter
The vaccination gave me soreness on my arm. I was doing my daily routine and I started feeling hives coming back on my cover and chest. Now is starting spread all over my neck. I have never had a reaction to anything. The rash has gotten worse. I got a steroid shot and a histamine. I was also told to take Benadryl and it should help with this burning and itching sensation. it is very painful to have any fabric over my skin.  I was also advised to see Dr. in Allergy Asthma & Immunology Clinic in town. He did blood work to check my thyroid, but everything came back normal.
face got swollen; This is a spontaneous report from a contactable consumer or other non-Health Care Professional.A 56-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EN6207 and Expiry date: Unknown), dose 1 via an unspecified route of administration on 12Apr2021 as DOSE 1, SINGLE for Covid-19 immunization. Medical history included blood cholesterol increased from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported.On 13Apr2021 the patient experienced face got swollen. The patient underwent lab tests and procedures which included covid-19: positive on 03Jan2021.Therapeutic measures were taken as a result of face got swollen. Patient took Benadryl ultra tab 25 mg, to manage the swelling .The outcome of event was unknown.  No follow-up attempts are needed. No further information is expected.
Swelling and pain in left upper arm x 2 months - still tender at injection site 11/29/18 appt.
Moderna COVID-19 Vaccine.  About 15 hours after I received the second injection I experienced severe chills, with chattering teeth, while trying to go to sleep.  This lasted for several hours.  By the morning the chills were gone.  My husband, who received the same vaccine at the same time had the same reaction--severe chills.
I had chills, aches and tiredness. Then I was heavy menstrual bleeding clots. My doctor thought I had endometriosis, polyps, cancer, I had 3 ultrasounds, a D&C scraping. I was passing out at work , I was weak, they were keeping an eye on my blood counts because I was losing blood, excessively bleeding. I was recommended to take Iron supplements. I had horrible cramps, excessive back pain.
2-25-03-Report came into Health Dept. of possible bacterial infection from site. Patient reports an area which is red, swollen, and hot approx. 2-3 cm. from actual site. Recommendation made to vary the position of the gauze and opsite. Also to culture the site before starting on any antibiotics. 2-27-03-Call back made to patient. She states that after varying the position of the gauze and opsite, the symptoms resolved overnight and she did not do the culture or take antibiotics.
Had 2nd covid vaccine shot April 8th at 1:15PM. Friday evening started feeing tingling in left arm and skin on stomach. Saturday noticed rash on stomach. Sunday rash had grown. Wend Sunday April 11th to urgent care and was diagnosed with shingles. Was given a 7 day prescription for Valtrex. Two weeks later finally beginning to to see a reduction in the rash and pain.